1. Home
  2. ABUS vs OXM Comparison

ABUS vs OXM Comparison

Compare ABUS & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.40

Market Cap

839.5M

Sector

Health Care

ML Signal

HOLD

Logo Oxford Industries Inc.

OXM

Oxford Industries Inc.

HOLD

Current Price

$38.73

Market Cap

675.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
OXM
Founded
2005
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
839.5M
675.3M
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
ABUS
OXM
Price
$4.40
$38.73
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$5.00
$38.00
AVG Volume (30 Days)
2.7M
405.5K
Earning Date
05-14-2026
06-10-2026
Dividend Yield
N/A
6.80%
EPS Growth
55.26
N/A
EPS
0.87
1.00
Revenue
$14,083,000.00
$1,477,834,000.00
Revenue This Year
N/A
$2.85
Revenue Next Year
$239.71
$2.63
P/E Ratio
$5.14
$38.17
Revenue Growth
128.21
N/A
52 Week Low
$3.25
$30.57
52 Week High
$5.38
$51.61

Technical Indicators

Market Signals
Indicator
ABUS
OXM
Relative Strength Index (RSI) 43.60 50.40
Support Level $4.16 $34.76
Resistance Level $4.69 $41.58
Average True Range (ATR) 0.24 2.00
MACD -0.06 0.39
Stochastic Oscillator 11.95 58.10

Price Performance

Historical Comparison
ABUS
OXM

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.

Share on Social Networks: